Authority: National Company Law Appellate Tribunal, Chennai Bench (Justice N. Seshasayee, Member (Judicial) and Jatindranath Swain, Member (Technical))
Order Date: September 21, 2026
Case Overview
This order pertains to two connected appeals filed before the National Company Law Appellate Tribunal (NCLAT) at Chennai:
- Company Appeal (AT) (CH) (Ins) No.507/2026 (with IA No.1431/2026)
- Company Appeal (AT) (CH) (Ins) No.509/2026 (with IA Nos.1434 & 1435/2026)
The Appellant in both appeals is Sri Botta Parvathaiah, identified as the Promoter, Chairman, and Suspended Director of Vivin Drugs and Pharmaceuticals Ltd, along with another appellant (Anr.).
The Respondents in both appeals are:
1. Rajesh Chillale, the Resolution Professional (RP) of Vivin Drugs and Pharmaceuticals Ltd & Vivin Laboratories Pvt Ltd
2. Five other respondents (5 Ors.)
The nature of the appeals challenges actions or decisions of the Resolution Professional in the corporate insolvency resolution process concerning Vivin Drugs and Pharmaceuticals Ltd and its related entity, Vivin Laboratories Pvt Ltd.
The hearing was conducted in hybrid mode. Ms. Vismaya MS, Advocate, accepted notice on behalf of Respondent No.1 (the Resolution Professional) in Appeal No.507/2026.
The tribunal reviewed an affidavit filed in support of an application for condonation of delay (IA No.1435/2026). The Bench expressed satisfaction with the reasons for the delay as stated in paragraph 3 of that affidavit.
Final Outcome
The NCLAT allowed the condonation of delay application (IA No.1435/2026). Consequently, both appeals (507/2026 and 509/2026) were admitted and listed for their next hearing on September 24, 2026, under the same caption.
Topics: NCLAT Proceedings, Corporate Insolvency, Pharma Sector